Tag archive for ‘Hyperion Therapeutics’
Globes On Tuesday, September 23rd, 2014

Clal Biotech Suing Hyperion for $200 Million over ‘Rash and Ill Considered’ Andromeda Decisions

Clal Biotechnology Industries Ltd. (TASE: CBI announced yesterday that it had filed a $200 million suit against drug company Hyperion Therapeutics Inc. (Nasdaq: HPTX) in the US in the State of Delaware Court, More...

Jewish Business News On Monday, September 22nd, 2014

Clal Biotech: No Evidence of Misconduct by Us

Clal Biotechnology Industries Ltd. (TASE: CBI) notified the Tel Aviv Stock Exchange this morning that it had contacted Hyperion Therapeutics Inc. (Nasdaq: HPTX) as part of its efforts to gather as much information More...

Globes On Tuesday, September 9th, 2014

Hyperion Cancels Israeli Biotech Acquisition over Falsified Clinical Trial Results

By Gali Weinreb and Shiri Habib-Valdhorn Hyperion says it has “uncovered evidence” that Andromeda falsified clinical trial results. Hyperion Therapeutics Inc. (Nasdaq: HPTX) has cancelled its acquisition More...

Jewish Business News On Thursday, April 24th, 2014

Hyperion Therapeutics acquires Israeli Andromeda Biotech for up to $570 million

– Hyperion Therapeutics (Nasdaq:HPTX) announced today that it acquires Andromeda Biotech Ltd., an Israel-based subsidiary of Clal Biotechnology Industries Ltd. (TASE:CBI), for $20 million in cash More...

Wordpress site Developed by Fixing WordPress Problems